ROTH Capital Partners Bolsters its Healthcare Franchise with Key Hires
NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Jan 10, 2020--
ROTH Capital Partners (ROTH), www.roth.com, a full service investment bank focused on serving emerging growth companies and their investors, is pleased to announce the following hires to its healthcare equity research, investment banking and institutional sales teams.
Jonathan Aschoff, Ph.D., has joined the firm’s Healthcare Research team as a Managing Director and Senior Research Analyst. He has over 20 years of sell-side analyst experience, covering small and micro-cap companies in the biotechnology sector. Dr. Aschoff earned a bachelor’s degree in Biology from Tufts University and a Ph.D. in Microbiology and Molecular Biology from Tufts University School of Medicine.
Jeff Smith, Ph.D., has joined ROTH as a Managing Director in the Healthcare Investment banking team. Dr. Smith’s investment banking experience has focused on advising small and mid-cap healthcare and biotechnology companies, participating in over 90 equity financing deals representing nearly $4 billion in aggregate value. He has advised and raised capital for companies across all therapeutic areas, with a special focus on oncology and metabolic diseases. Prior to entering the investment banking field, he spent nine years as a laboratory manager and researcher studying insulin signaling and glucose transport in Type 2 Diabetes. Dr. Smith holds a Bachelor of Science (Honors) in Chemistry from the University of Iowa, and received his Ph.D. from Memorial Sloan Kettering Cancer Center.
Grant Hall and Tony Caserta have joined ROTH as Managing Directors in Institutional Sales. Both have extensive experience in providing sell-side services to institutional portfolio managers and investment advisors. Grant, who previously worked in institutional sales at Raymond James, Wedbush, Robert W. Baird and Deutsche Bank Securities, will be located in Boston, and Tony, who previously worked in institutional sales at Summer Street Research, Leerink Partners and Oppenheimer, will be based in ROTH’s New York office . Mr. Hall holds a B.A. from University of Vermont, and Mr. Caserta received his B.S. from Villanova University.
“We look forward to working with these highly experienced additions to our healthcare team,” said Byron Roth, CEO of ROTH Capital Partners. “We believe that their collective expertise will help further solidify our research, banking and sales capabilities as we endeavor to be one of the leading investment banks for emerging healthcare companies and their investors.”
Since 2010, ROTH has completed over 460 healthcare transactions, raising approximately $18.5 billion for its clients.
About Roth Capital Partners, LLC:
ROTH Capital Partners, LLC (ROTH), is a relationship-driven investment bank focused on serving emerging growth companies and their investors. As a full-service investment bank, ROTH provides capital raising, M&A advisory, analytical research, trading, market-making services and corporate access.
Headquartered in Newport Beach, Calif., ROTH is privately-held and owned by its employees, and maintains offices throughout the U.S. For more information on ROTH, please visit www.roth.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20200110005521/en/
CONTACT: Investor and Media Contact:
ROTH Capital Partners
Director of Marketing
KEYWORD: UNITED STATES NORTH AMERICA MARYLAND CALIFORNIA NEW YORK
INDUSTRY KEYWORD: FINANCE BANKING OTHER HEALTH HEALTH PROFESSIONAL SERVICES
SOURCE: ROTH Capital Partners
Copyright Business Wire 2020.
PUB: 01/10/2020 02:55 PM/DISC: 01/10/2020 02:55 PM